Literature DB >> 33020332

Test, Trace, and Treatment Strategy to Control COVID-19 Infection Among Hospital Staff in a COVID-19 Referral Hospital in Indonesia.

Rakhmad Hidayat1, Nurul Aini, Azizah Fitriana Nurul Ilmi, Faiza Azzahroh, Astuti Giantini.   

Abstract

BACKGROUND: COVID-19 infection is caused by a novel coronavirus. One of the most used strategies that can be used to control the spread of COVID-19 is the 3T (test, trace, and treatment) strategy. This study aimed to evaluate the 3T strategy to control COVID-19 infection in a COVID-19 Referral Hospital in Depok, West Java, Indonesia.
METHODS: this is a cross-sectional study conducted at the University of Indonesia Hospital. The study was conducted in June 2020 with 742 participants (staff members) using secondary data from polymerase chain reaction (PCR) test results. We presented data in the descriptive form and performed bivariate analysis using the chi-square/Fischer test for categorical data.
RESULTS: the PCR test results were positive in 83 (11.1%) participants, with a case-per-tracing ratio of 1:24 and 1:2 in the first and third phases of tracing, respectively. The COVID-19 case graph for the participants decreased along with the implementation of the 3T strategy. The positivity rate in the first phase of tracing was 20% and decreased to 5% in the third phase of tracing. Staff with confirmed positive test results were advised to isolate themselves (hospital or self-isolation). Hospital isolation was found to be associated with the duration of PCR test conversion (p<0.001).
CONCLUSION: the 3T strategy is effective for controlling the spread of COVID-19. The strategy should be implemented simultaneously with other health precautions to reduce the risk of spreading infection.

Entities:  

Keywords:  3T strategy; COVID-19; PCR test; Universitas Indonesia Hospital

Mesh:

Substances:

Year:  2020        PMID: 33020332

Source DB:  PubMed          Journal:  Acta Med Indones        ISSN: 0125-9326


  4 in total

1.  A method for campus-wide SARS-CoV-2 surveillance at a large public university.

Authors:  Terren Chang; Jolene M Draper; Anouk Van den Bout; Ellen Kephart; Hannah Maul-Newby; Yvonne Vasquez; Jason Woodbury; Savanna Randi; Martina Pedersen; Maeve Nave; Scott La; Natalie Gallagher; Molly M McCabe; Namrita Dhillon; Isabel Bjork; Michael Luttrell; Frank Dang; John B MacMillan; Ralph Green; Elizabeth Miller; Auston M Kilpatrick; Olena Vaske; Michael D Stone; Jeremy R Sanford
Journal:  PLoS One       Date:  2021-12-17       Impact factor: 3.752

2.  The role of routine SARS-CoV-2 screening of healthcare-workers in acute care hospitals in 2020: a systematic review and meta-analysis.

Authors:  J M Jabs; A Schwabe; A D Wollkopf; B Gebel; J Stadelmaier; S Erdmann; F Radicke; H Grundmann; A Kramer; I Monsef; G Rücker; J Rupp; S Scheithauer; C Schmucker; A Simon; Nico T Mutters
Journal:  BMC Infect Dis       Date:  2022-07-02       Impact factor: 3.667

Review 3.  Prognosis of COVID-19 in the middle eastern population, knowns and unknowns.

Authors:  Iman Dandachi; Waleed Aljabr
Journal:  Front Microbiol       Date:  2022-08-31       Impact factor: 6.064

4.  Effects of Casirivimab/Imdevimab Monoclonal Antibody Treatment among Vaccinated Patients Infected by SARS-CoV-2 Delta Variant.

Authors:  Gaetano Cicchitto; Lorena Cardillo; Claudio de Martinis; Paola Sabatini; Rosita Marchitiello; Giovanna Abate; Adele Rovetti; Antonietta Cavallera; Camillo Apuzzo; Francesco Ferrigno; Giovanna Fusco
Journal:  Viruses       Date:  2022-03-21       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.